Regional anaesthesia

The diaphragm-sparing effect of interscalene block with a low-volume of ropivacaine 0.1% vs. 0.5%%: A double-blind, controlled, randomised trial

Eur J Anaesthesiol Intensive CarePublished Randomised controlled trial

Primary result · Hemidiaphragmatic dysfunction (decrease in diaphragm excursion >25% of baseline)Result — go to the resultRelative risk 0.24 95% CI 0.13–0.46

Authors' conclusion

ISB with 7 ml of ropivacaine 0.1% is associated with a lower incidence of hemidiaphragmatic dysfunction, when compared with the same volume of ropivacaine 0.5%, but at the cost of potentially less effective postoperative analgesia.

Study context

Population
Patients undergoing shoulder arthroscopy under GA, tertiary university hospital
Participants
60 patients
Comparison
Ultrasound-guided ISB with 7 ml ropivacaine 0.1% vs 0.5%
Primary endpoint
Incidence of hemidiaphragmatic dysfunction (decrease in diaphragm excursion >25% of baseline)
Follow-up
30 min after ISB
Methodological detailssingle-centre
  • Single-centre

Primary result

As reported in the abstract

Hemidiaphragmatic dysfunction (decrease in diaphragm excursion >25% of baseline)

Relative risk

0.24

95% CI 0.13–0.46

P < 0.001

Events by treatment group

Experimental vs Control
RR 0.24 (95% CI 0.13–0.46); P < 0.001

Secondary outcomes

Duration of effective analgesia · Log-rank test; not significant

P = 0.23

OutcomeMean difference in restricted mean survival time (h) (95% CI)P value
Duration of effective analgesia−3.2 (−6.4 to 0.2)P = 0.061
OutcomeExperimentalControlP value
Hemidiaphragmatic paralysis (decrease in diaphragm excursion >75% of baseline)1 events25 eventsP < 0.001
Decrease in forced vital capacityMedian, %−17 (IQR −23–-5)−29 (IQR −42–-6)P = 0.039
Postoperative morphine requirement10 events3 eventsP = 0.028

Original publication

The diaphragm-sparing effect of interscalene block with a low-volume of ropivacaine 0.1% vs. 0.5%%: A double-blind, controlled, randomised trial. Eur J Anaesthesiol Intensive Care. Published 23 April 2026. doi:10.1097/ea9.0000000000000108

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.